Short interest in ADMA stock dropped 10% in the latest reporting period, reinforcing bullish ADMA stock forecast sentiment among momentum-focused traders. In the chart below, we zoom in on the different ownership groups of ADMA Biologics. There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices. ADMA stock forecast benefits from resilient demand for plasma therapies despite macroeconomic headwinds, as healthcare sector spending remains robust.
